Form 4 for WST West Pharmaceutical Services
Accepted 2023-05-02 00:00:00 ET · period of report 2023-05-01 · accession 0001562180-23-003795 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-02 | 2023-05-01 | WST | Abraham Silji | SVP, CTO | S - Sale+OE | $365.60 | -8,020 | 4,858 | -62% | -$2.93M |
| D | 2023-05-02 | 2023-05-01 | WST | Abraham Silji | SVP, CTO | M - OptEx | $86.24 | +8,020 | 12.2K | +191% | +$691.6K |
| D | 2023-05-02 | 2023-05-01 | WST | Abraham Silji | SVP, CTO | M - OptEx | $0.00 | -8,020 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | S | D | 649 | $366.14 | 4,209.30 | D | — | — | (F2) The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $366.0350 to $366.18, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| 2 | Common | Common Stock | 2023-05-01 | M | A | 8,020 | $86.24 | 12,229.30 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-01 | S | D | 7,371 | $365.55 | 4,858.30 | D | — | — | (F1) The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $365.00 to $365.91, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| 4 | Derivative | Stock Options (Right to Buy) | 2023-05-01 | M | D | 8,020 | $0.00 | 0 | D | $86.24 · 2019-02-26 to 2028-02-26 | 8,020 Common Stock | (F3) This award vests in 4 equal annual installments beginning on 2/26/2019. |